Incyte supports significant independent research aimed at advancing the study of our products and compounds and/or related to disease areas of interest through its Investigator-initiated research (IIR) program. This program is open to physicians, researchers, and institutions interested in conducting external research.
If you have questions about investigator-initiated research or are interested in submitting a research proposal, please contact us at iir.incyte.com.
EXPANDED ACCESS PROGRAM
lncyte believes that conducting clinical trials to obtain the necessary approvals provides patients with the optimal mechanism for broad access to medicines. We recognize that some patients with serious or immediately life-threatening diseases may not be eligible for participation in a clinical trial, or may not have other options. Subject to appropriate internal review and approval based on the conditions in Incyte's Policy on Compassionate Use, Incyte in its sole discretion may choose to provide individual patients with access to an unapproved or investigational product outside of a clinical trial setting.Show More Information
Requesting Incyte Expanded Access
If clinical trials are not an option, applying for expanded access may be something for treating physicians and patients to consider.
On behalf of the patient, a treating physician must make a formal request. This will enable collaboration directly with Incyte physicians to determine the next steps. Requesting access to an Incyte investigational medicine will only be considered if the patient's treating physician is committed to, and supportive of, the requested treatment.
Once Incyte has received the request and all of the required medical information, we will respond as soon as possible. If the request is approved by Incyte, the applicable Regulatory authority will need to grant final approval before Incyte can ship the investigational medicine to the requesting physician.
View Full Expanded Access Policy
Physicians based in the United States may make a formal request on behalf of their patient by calling
Outside of the United States, physicians may contact
Per country requirements, you may be required to dial (+), (0), or (00) before the free phone number. The +800 00027423 number is active in the following countries: AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MT, NL, NO, PL, PT, RU, SE, SK, and SI.
The clinical trials listed on this website are Incyte-sponsored trials that are actively recruiting patients. To get additional information about Incyte-sponsored trials, such as study description, eligibility criteria, contact information, and facility names, please visit ClinicalTrials.gov.
REQUEST AN OFFICE VISIT WITH AN INCYTE MEDICAL SCIENCE LIAISON
If you are in the United States and have a question about a clinical trial or want to meet with a Medical Science Liaison, please click "OPEN" and fill out the form below to contact our Medical Information team.Show More Information
INCYTE EDUCATIONAL GRANTS
Incyte supports the advancement of medical education as part of its commitment to address unmet needs. Through appropriate funding of educational grants to institutions, Incyte will support medically sound and compliant continuing education aimed at enhancing the knowledge of healthcare professionals and improving patient care.
To submit a grant request, please go to incytegrantsandgiving.com.
Click here to read our Clinical Trial Transparency, Data Sharing, and Disclosure Practices.